Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

Timothy J. Scannell

At a glance: Timothy J. Scannell is Director at NovoCure (NVCR). Their latest SEC Form 4, filed Jun 3, 2026, reported a sale of $46K. On file: 0 purchase lines ($0) and 1 sale line ($46K).

Disclosed holdings: about $152K of NVCR stock: 14,288 shares reported on their latest Form 4 (filed Jun 3, 2026), valued at the Nov 19, 2026 close of $10.65. This counts only NVCR shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.

Director at NovoCure Ltd (NVCR)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $46K

Reported trades

Filed Stock Type Shares Price Value Since
Jun 3SEC NVCRNovoCure Ltd Sell 2,94514,288 held (−17%) $15.77 $46K -32.5%

Follow Timothy J. Scannell

Get one email when Timothy J. Scannell files a new purchase or sale. Free.

At most one email a day about Timothy J. Scannell, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.